Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP414538.RA1mCU3Qw36lgtXj3ZdSmN2w4uOZpnwgW67NrMg0jTGVY130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP414538.RA1mCU3Qw36lgtXj3ZdSmN2w4uOZpnwgW67NrMg0jTGVY130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP414538.RA1mCU3Qw36lgtXj3ZdSmN2w4uOZpnwgW67NrMg0jTGVY130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP414538.RA1mCU3Qw36lgtXj3ZdSmN2w4uOZpnwgW67NrMg0jTGVY130_provenance.
- befree-20150227 importedOn "2015-02-27" NP414538.RA1mCU3Qw36lgtXj3ZdSmN2w4uOZpnwgW67NrMg0jTGVY130_provenance.
- NP414538.RA1mCU3Qw36lgtXj3ZdSmN2w4uOZpnwgW67NrMg0jTGVY130_assertion wasGeneratedBy ECO_0000203 NP414538.RA1mCU3Qw36lgtXj3ZdSmN2w4uOZpnwgW67NrMg0jTGVY130_provenance.
- NP414538.RA1mCU3Qw36lgtXj3ZdSmN2w4uOZpnwgW67NrMg0jTGVY130_assertion wasDerivedFrom befree-20150227 NP414538.RA1mCU3Qw36lgtXj3ZdSmN2w4uOZpnwgW67NrMg0jTGVY130_provenance.
- NP414538.RA1mCU3Qw36lgtXj3ZdSmN2w4uOZpnwgW67NrMg0jTGVY130_assertion SIO_000772 19673887 NP414538.RA1mCU3Qw36lgtXj3ZdSmN2w4uOZpnwgW67NrMg0jTGVY130_provenance.
- NP414538.RA1mCU3Qw36lgtXj3ZdSmN2w4uOZpnwgW67NrMg0jTGVY130_assertion evidence source_evidence_literature NP414538.RA1mCU3Qw36lgtXj3ZdSmN2w4uOZpnwgW67NrMg0jTGVY130_provenance.
- NP414538.RA1mCU3Qw36lgtXj3ZdSmN2w4uOZpnwgW67NrMg0jTGVY130_assertion description "[Oral administration of gefitinib significantly (P < 0.001) reduced tumor growth of xenografts of three HNSCC cell lines (HSC-2, HSC-3, and HSC-4), in female athymic nude mice, accompanied by an increase in BRAK expression specifically in tumor tissue.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP414538.RA1mCU3Qw36lgtXj3ZdSmN2w4uOZpnwgW67NrMg0jTGVY130_provenance.